Publication | Closed Access

Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies

Hematological MalignancyMyelodysplastic SyndromeClinical UtilityGeneticsMyeloid MalignanciesHematologyMedicinePathologyMalignant Blood DisorderNext-generation SequencingGenomicsMolecular DiagnosticsSequencingCancer ResearchMyeloid Neoplasia